Beida Pharmaceutical's shareholder, Kaiming Investment, supplements pledge of 168.5k shares

MaticHoleFiller · 2026-04-09T00:50:47+00:00

Betta Pharmaceuticals announces that some of its shareholder Kaiming Investment's shares have been pledged, involving 168,500 shares, with the pledge period until October 2026. The pledge does not involve new financing. The controlling shareholder and its concerted parties' pledged shares account for nearly 12% of the total share capital. The company states that the risk is controllable and does not affect the actual control.

MaticHoleFiller

2026-04-09 00:50:47

Abstract generation in progress

Sina Finance app data Fucheng data Beijing-Fu Pharmaceutical Co., Ltd. today released an announcement disclosing that a portion of the shares held by its shareholder Ningbo Kaiming Investment Management Partnership Enterprise (Limited Partnership) has undergone pledged share changes. This change is an add-on pledge, involving 168,500 shares, accounting for 0.21% of the shares held by Kaiming Investment and 0.04% of the company’s total share capital. The pledge start date is March 24, 2026, and the due date is October 23, 2026. The pledgee is Zhejiang Securities Co., Ltd.

As of the date of disclosure in the announcement, Kaiming Investment and its persons acting in concert—Zhejiang Becheng Investment Management Partnership Enterprise (Limited Partnership) and Ding Lieming—together hold 91,012,801 shares of the company, accounting for 21.63% of the company’s total share capital. After this add-on pledge, the controlling shareholder and its persons acting in concert have cumulatively pledged 50,256,904 shares, accounting for 55.22% of the total number of shares they hold and 11.95% of the company’s total share capital. The announcement states that this pledge is an add-on pledge, does not involve新增融资, and also does not involve using the pledged financing to support the company’s production and operations.

The announcement also discloses the relevant repayment arrangements and risk assessment for the pledged shares. In the next six months, the financing balance corresponding to the pledged shares that will mature for the controlling shareholder and its persons acting in concert is RMB 255 million; within the next one year (excluding the portion maturing within the next six months), the financing balance corresponding to the pledged shares is RMB 250 million. The company stated that the repayment funds will come from its own funds or self-raised funds. At present, there is no risk of pledged shares being liquidated or forcibly transferred. The overall risk is controllable and will not lead to any change in the company’s actual controlling interest. The company will continue to monitor the shareholders’ pledged share situation and promptly fulfill its information disclosure obligations.

Huge amounts of information, precise insights—right on the Sina Finance app

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.